News
Pharmaceutical Technology on MSN6d
Ascletis’s daily acne tablet set for China review after Phase III winThe Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to ...
Ascletis Pharma’s acne pill has scored a phase 3 win, leading the Chinese biotech to claim the Sagimet Biosciences-sourced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback